首页> 外文期刊>Pathology Research and Practice >Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays.
【24h】

Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays.

机译:Janus激酶3(JAK3),基质金属蛋白酶13(MMP13),热休克蛋白60(HSP60)和小鼠双分2(MDM2)在人结肠直肠癌进展中使用人癌cDNA微阵列的差异表达。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we applied commercially available cDNA microarray systems (1068 genes) to investigate the genetic changes in six colorectal cancers (CRC). Thirty-two genes fell into the group of commonly upregulated genes. In addition, we immunohistochemically investigated the expression of the four top ranked upregulated genes, Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2), in 44 CRC. JAK3 staining was located in the cancer cells. A comparison of JAK3 immunostaining and clinicopathological parameters showed a significant association of tumor differentiation, pT, and TMN stage. Staining of MMP13 and HSP60 was noted mainly in the cytoplasm of cancer cells. A significant association of these expressions was observed with tumor differentiation and pT. MDM2 staining was noted in the nucleus of cancer and non-cancer cells. No significant association of clinicopathological parameters with MDM2 expression was observed. In multivariate analysis, JAK3 immunoreactivity showed independent prognostically unfavorable predictors. These data suggest that JAK3, in particular, is a highly significant, prognostic immunohistochemical marker in CRC. This study proves that cDNA microarrays, plotted by a small number of genes from a few samples, are both practical and useful.
机译:在这项研究中,我们应用了市售的cDNA微阵列系统(1068个基因)来研究六种大肠癌(CRC)的遗传变化。 32个基因属于常见的上调基因。此外,我们免疫组化研究了44种CRC中四个排名最高的上调基因Janus激酶3(JAK3),基质金属蛋白酶13(MMP13),热休克蛋白60(HSP60)和小鼠双分2(MDM2)的表达。 。 JAK3染色位于癌细胞中。 JAK3免疫染色和临床病理参数的比较显示肿瘤分化,pT和TMN阶段显着相关。 MMP13和HSP60的染色主要在癌细胞的细胞质中发现。观察到这些表达与肿瘤分化和pT显着相关。在癌细胞和非癌细胞的细胞核中发现了MDM2染色。没有观察到临床病理参数与MDM2表达的显着关联。在多变量分析中,JAK3免疫反应性显示独立的预后不良预测因子。这些数据表明,JAK3特别是CRC中高度重要的预后免疫组织化学标记。这项研究证明,由少量样品中的少量基因作图的cDNA微阵列既实用又有用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号